CDKN2A and cancer: The INK4B-ARF-INK4A locus has previously been shown to be a key target of Ezh2 in other cells, including epidermal stem cells11, pancreatic beta cells21, muscle satellite cells22, haematopoietic stem cells23 and numerous cancer cells24, 25.